Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × exemestane × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Endometrial Hyperplasia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Bupivacaine 2 pyrotinib 1 exemestane 1 abemaciclib 1 Tumor Burden 1 Thioctic Acid 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1 Mastectomy 1 Mammaplasty 1 Letrozole 1 Drug Therapy 1 Dexmedetomidine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡